Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for Treatment-resistant Major Depressive Disorder
NCT00408031Phase 2Completed
- Sponsor
- Herzog Hospital
- Start
- Jan 2007
- Primary completion
- May 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in major depressive disorder (MDD), sponsored by Herzog Hospital. Started Jan 2007; status: completed.
02
Drugs
d-cycloserine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00408031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408031.